Nocturnal BiPAP Therapy Improved Chronic Respiratory Failure in Chilaiditi Syndrome.

BACKGROUND

Chilaiditi syndrome includes the Chilaiditi sign, a radiological finding where a segment of bowel loop or small intestine has wandered between the liver and diaphragm and also any symptoms related to intestinal interference.

CASE PRESENTATION: We report the case of a 79-year-old man with Chilaiditi syndrome whose dyspnea and sleep disturbance improved after nocturnal biphasic positive airway pressure (BiPAP) therapy implementation.

DISCUSSION: BiPAP therapy may contribute to thoracic pressure elevation and reduce diaphragmatic compression due to intestinal enlargement, thus leading to improvements in respiratory symptoms.

CONCLUSION

BiPAP therapy should therefore be considered as a treatment option for Chilaiditi syndrome patients.